Industry Intelligence · Healthcare & Wellness
Health promotion sits at the intersection of Drugs & Cosmetics rules, ASCI healthcare guidelines, CCPA misleading-ad standards, and — where insurance is bundled — IRDAI expectations.
Overview
ASCI Addendum II (April 2025) requires influencers to hold and disclose relevant credentials when making technical prevention, treatment, or remedy claims for health and nutrition products — not for purely generic wellness messaging. Telehealth and app brands still face CCPA action on subscription dark patterns and unsubstantiated outcome claims.
Schedule H/H1 boundaries, magic remedies prohibitions, and cosmetics rules apply to social copy — not only pack labels. State drug controllers and ASCI uphold complaints on before/after imagery, doctor impersonation, and influencer-led cure narratives; insurers overlap when health plans are marketed alongside apps.
Technical health claims require appropriate qualifications (e.g. medical, nursing, nutrition credentials depending on claim type); generic wellness promotions treated differently from expert advice.
ASCI guidelines →FSSAI’s influencer warning on food claims affects wellness brands selling supplements and functional foods — same substantiation expectations apply to cross-category health creators.
FSSAI →Applies to health app onboarding, subscription boxes, and telehealth lead funnels — frequently enforced alongside misleading ad provisions.
CPA 2019 →Summaries are for orientation only; rely on official ASCI, state drug controller, and CCPA publications for compliance decisions.
PACK_GLOBAL with ASCI healthcare, DMR/D&C-aligned checks, and CCPA dark-pattern detectors — Distribution Monitoring on affiliates and creators; PrePub Check for owned health creatives before campaigns launch.
